Bulk Pharmaceutical API Sources for THEOPHYLLINE 0.08% AND DEXTROSE 5% IN PLASTIC CONTAINER

Bulk Pharmaceutical API Sources for THEOPHYLLINE 0.08% AND DEXTROSE 5% IN PLASTIC CONTAINER

Vendor	Vendor Homepage	Vendor Sku	API Url
Hangzhou APIChem Technology		AC-12160
ABI Chem		AC1L3LQJ
Ambinter		T1505
ChemMol		30101964
TimTec		ST50411853
IS Chemical Technology		I14-62379
AKos Consulting & Solutions		AKOS015960702

Last updated: August 15, 2025

lk Active Pharmaceutical Ingredient (API) Sources for Theophylline 0.08% and Dextrose 5% in Plastic Container

Introduction

The formulation of injectable solutions, such as Theophylline 0.08% and Dextrose 5% in plastic containers, necessitates sourcing high-quality bulk APIs. Ensuring pharmaceutical-grade API supply is critical for regulatory compliance, product safety, and efficacy. This analysis provides a comprehensive overview of global API suppliers capable of providing Theophylline and Dextrose suitable for hospital and commercial use, emphasizing quality standards, supply reliability, and market dynamics.

Theophylline API: Overview and Key Sources

Chemical Profile and Usage
Theophylline is a methylxanthine derivative used primarily as a bronchodilator for respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD). In injectable formulations, Theophylline must adhere to strict purity standards (usually USP or Ph. Eur.), ensuring minimal impurities and high bioavailability.

Global API Suppliers for Theophylline
Leading suppliers of Theophylline API include established pharmaceutical chemical manufacturers in Asia, Europe, and North America. Key players focus on GMP-compliant production, ensuring APIs meet pharmacopeial standards.

• Zhejiang Huahai Pharmaceutical Co., Ltd. (China)
  One of the largest producers of life sciences chemicals, Zhejiang Huahai supplies Theophylline API meeting international standards. The company emphasizes compliance with GMP, ISO, and pharmacopeial requirements, making it a reliable source for pharmaceutical manufacturers globally.

• Shenzhen Fealt Healthcare Co., Ltd. (China)
  Specializing in bulk APIs, this manufacturer offers high-purity Theophylline suitable for injectable forms with proven stability and purity profiles.

• Sogeval Laboratories (India)
  Sogeval is renowned for its pharmaceutical intermediates and APIs, providing Theophylline API conforming to USP and other pharmacopeial standards with consistent supply capability.

• Hikma Pharmaceuticals (UK)
  A global pharmaceutical company with in-house manufacturing for APIs, Hikma ensures rigorous quality controls, positioning it as a trusted supplier for high-purity Theophylline API.

• Eurapharma Ltd. (Germany)
  Known for supplying pharmaceutical raw materials across Europe; Eurapharma offers pharmaceutical-grade Theophylline API meeting GMP, USP, and Ph. Eur. specifications.

Dextrose (D-glucose) 5% API: Overview and Key Sources

Chemical Profile and Usage
Dextrose 5% in water (Dextrose 5%) is a standard infusion solution providing glucose, a vital source of energy, especially in hospital settings. The API is the raw material used in manufacturing sterile Dextrose solutions, which must be of high purity, endotoxin-free, and free from particulates.

Global API Suppliers for Dextrose
Dextrose API sourcing is generally concentrated in large-scale carbohydrate producers with high-quality standards aligning with pharmacopeial requirements.

• Cargill, Inc. (USA)
  A leading supplier of dextrose monohydrate globally, Cargill’s API-grade dextrose meets USP, FCC, and Ph. Eur. standards, with extensive production capacity suitable for bulk pharmaceutical manufacturing.

• Roquette Frères (France)
  Specialized in specialty carbohydrates, Roquette offers pharmaceutical-grade Dextrose API, with strict quality controls and supply chain guarantees meeting global standards.

• ADM (Archer Daniels Midland) (USA)
  ADM produces high-purity dextrose APIs primarily used in parenteral and enteral nutrition, with certifications aligning with pharmacopeials for injectable use.

• Shandong Safe Biotechnology Co., Ltd. (China)
  This company supplies pharmaceutical-grade dextrose with comprehensive certifications, focusing on stability and endotoxin levels apt for injectable solutions.

• Meiji Seika Pharma (Japan)
  Known for pharmaceutical-grade carbohydrates, Meiji offers Dextrose API conforming to strict quality standards suitable for sterile formulations.

Quality Standards and Regulatory Considerations

For injectable APIs, manufacturers must ensure compliance with international pharmacopeial standards, such as USP, Ph. Eur., or JP. APIs used in sterile, injectable formulations require thorough testing for contaminants—heavy metals, microbial endotoxins, residual solvents, and particulate matter.

Regulatory pathways
Suppliers must possess GMP certification, with documentation of Batch Manufacturing Records, Certificates of Analysis, and stability data. Many of the mentioned suppliers provide comprehensive dossiers aligned with FDA, EMA, and other regulatory agency requirements, facilitating seamless integration into formulations.

Market Dynamics and Supply Chain Considerations

The demand for pharmaceutical-grade Theophylline API remains moderate but stable, primarily driven by respiratory medication needs. Conversely, Dextrose API experiences high demand, given its widespread application in IV solutions, nutritional products, and dialysis fluid manufacturing.

Supply chain risks include geopolitical factors, regulatory changes, and capacity limitations, especially during global crises like pandemics. Diversifying sources across regions—Asia, Europe, and North America—is vital for supply resilience.

Conclusion

Sourcing high-quality bulk APIs for Theophylline 0.08% and Dextrose 5% in plastic containers requires selecting suppliers with proven GMP compliance, global regulatory acceptance, and robust quality assurance frameworks. Suppliers such as Zhejiang Huahai, Cargill, Roquette, and ADM stand out for their capacity to deliver consistent, pharmacopeial-grade APIs suitable for pharmaceutical manufacturing.

Key Takeaways

• Reliable API sourcing hinges on strict adherence to GMP and pharmacopeial standards.
• Asia remains a major hub for Theophylline API production, with several reputable suppliers.
• Dextrose API suppliers span North America, Europe, and China, with capacity to supply large volumes for intravenous formulations.
• Diversifying suppliers mitigates supply chain risks and ensures continuous production.
• Robust qualification and documentation are critical for regulatory approval and compliance.

FAQs

1. What factors should I consider when selecting an API supplier for injectable Theophylline?
Prioritize GMP certification, compliance with pharmacopeial standards (USP, Ph. E., JP), quality control measures, supply capacity, and regulatory support.

2. Are APIs from Chinese manufacturers suitable for strict regulatory environments like the EU or US?
Yes, many Chinese API producers have achieved GMP certification and can supply APIs meeting international standards. However, thorough qualification and documentation are essential.

3. How is the quality of Dextrose API verified for injectable use?
Through Certificates of Analysis, microbial endotoxin testing, particle count assessments, heavy metal limits, and stability trials aligning with pharmacopeial monographs.

4. Can I source Theophylline API directly from pharmaceutical companies?
Yes, major pharmaceutical APIs are available directly through manufacturers with appropriate licensing, certifications, and registration. Distributors can also provide bulk APIs.

5. What current market challenges affect API supply for injectable formulations?
Global supply chain disruptions, regulatory barriers, capacity limitations, and geopolitical tensions can impact the availability and price of APIs. Diversification and early qualification are recommended strategies.

References

1. United States Pharmacopeia. USP General Chapter <791> Residual Solvents.
2. European Pharmacopoeia. Monograph on Theophylline.
3. Cargill official website. API-grade Dextrose specifications.
4. Zhejiang Huahai Pharmaceutical Product Catalog.
5. World Health Organization. Guidelines on the quality, safety, and efficacy of pharmaceuticals.